CY1111700T1 - Αναστολεις των νουκλεοζιτικων φωσφορυλασων και νουκλεοζιδασων - Google Patents

Αναστολεις των νουκλεοζιτικων φωσφορυλασων και νουκλεοζιδασων

Info

Publication number
CY1111700T1
CY1111700T1 CY20111100673T CY111100673T CY1111700T1 CY 1111700 T1 CY1111700 T1 CY 1111700T1 CY 20111100673 T CY20111100673 T CY 20111100673T CY 111100673 T CY111100673 T CY 111100673T CY 1111700 T1 CY1111700 T1 CY 1111700T1
Authority
CY
Cyprus
Prior art keywords
nucleoside
phosphorylases
compounds
inhibits
methylthioadenosine
Prior art date
Application number
CY20111100673T
Other languages
English (en)
Inventor
Gary Brian Evans
Richard Hubert Furneaux
Dirk Henning Lenz
Vern L Schramm
Peter Charles Tyler
Olga Vladimirovna Zubkova
Original Assignee
Albert Einstein College Of Medicine Of Yeshiva University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert Einstein College Of Medicine Of Yeshiva University filed Critical Albert Einstein College Of Medicine Of Yeshiva University
Publication of CY1111700T1 publication Critical patent/CY1111700T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Seal Device For Vehicle (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε ενώσεις του γενικού τύπου (I) οι οποίες είναι αναστολείς πουρινονουκλεοζιτικών φωσφορυλασών (ΡΝΡ), πουρινοφωσφοριβοσυλοτρανσφερασών (PPRT), 5'-μεθυλθειοαδενοσινε φωσφορυλασών (MTAP), 5'-μεθυλθειοαδενοσινε νουκλεοζιδασών (ΜΤΑΝ) και/ή νουκλεοζιτικών υδρολασών (ΝΗ). Η εφεύρεση αναφέρεται επίσης στην χρήση αυτών των ενώσεων στην θεραπευτική αγωγή νόσων και λοιμώξεων που περιλαμβάνουν καρκίνο, βακτηριακές λοιμώξεις, πρωτοζωϊκές λοιμώξεις και νόσο διαμεσολαβούμενη από Τ-κύτταρα και σε φαρμακευτικές συνθέσεις που περιέχουν τις συνθέσεις.
CY20111100673T 2002-08-21 2011-07-12 Αναστολεις των νουκλεοζιτικων φωσφορυλασων και νουκλεοζιδασων CY1111700T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ52091902 2002-08-21
EP03792904A EP1539783B1 (en) 2002-08-21 2003-08-21 Inhibitors of nucleoside phosphorylases and nucleosidases

Publications (1)

Publication Number Publication Date
CY1111700T1 true CY1111700T1 (el) 2015-10-07

Family

ID=31944950

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100673T CY1111700T1 (el) 2002-08-21 2011-07-12 Αναστολεις των νουκλεοζιτικων φωσφορυλασων και νουκλεοζιδασων

Country Status (17)

Country Link
US (2) US7553839B2 (el)
EP (1) EP1539783B1 (el)
JP (1) JP4682314B2 (el)
KR (1) KR101081226B1 (el)
CN (1) CN100379750C (el)
AT (1) ATE505474T1 (el)
AU (1) AU2003258911B2 (el)
BR (1) BRPI0313664B8 (el)
CA (1) CA2496698C (el)
CY (1) CY1111700T1 (el)
DE (1) DE60336734D1 (el)
DK (1) DK1539783T3 (el)
ES (1) ES2363766T3 (el)
PT (1) PT1539783E (el)
RU (1) RU2330042C2 (el)
SI (1) SI1539783T1 (el)
WO (1) WO2004018496A1 (el)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985848A (en) 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
CA2696826C (en) * 1999-04-08 2013-01-08 Industrial Research Limited Process for preparing inhibitors of nucleoside metabolism
CN100379750C (zh) 2002-08-21 2008-04-09 阿尔伯爱因斯坦医科叶希瓦大学 核苷磷酸化酶和核苷酶抑制剂
NZ523970A (en) * 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
TW200519116A (en) * 2003-08-26 2005-06-16 Teijin Pharma Ltd Pyrrolopyrimidine derivatives
NZ533360A (en) * 2004-06-04 2007-02-23 Ind Res Ltd Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
WO2006014913A2 (en) * 2004-07-27 2006-02-09 Biocryst Pharmaceuticals, Inc. Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase
NZ540160A (en) * 2005-05-20 2008-03-28 Einstein Coll Med Inhibitors of nucleoside phosphorylases
EP1924684A4 (en) * 2005-07-27 2009-02-11 Einstein Coll Med Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
NZ544187A (en) * 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
US20090053221A1 (en) * 2006-01-17 2009-02-26 Cheung Nai-Kong V Immune response enhancing glucan
US8394950B2 (en) * 2006-02-22 2013-03-12 Industrial Research Limited Analogues of coformycin and their use for treating protozoan parasite infections
AU2006200809B2 (en) * 2006-02-24 2013-11-07 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating cancer
JP2009527550A (ja) * 2006-02-24 2009-07-30 アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ 癌を処置する方法
US20110092521A1 (en) * 2006-02-24 2011-04-21 Richard Hubert Furneaux Methods of Treating Diseases Using Inhibitors of Nucleoside Phosphorylases and Nucleosidases
CN101094080B (zh) * 2006-06-22 2012-06-20 华为技术有限公司 一种即按即通系统中的计费方法
HRP20110408T1 (hr) 2006-09-07 2011-06-30 Industrial Research Limited Inhibitori nukleozidnih fosforilaza i hidrolaza acikličkog amina
US8383636B2 (en) 2006-09-07 2013-02-26 Industrial Research Limited Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
AU2007338953A1 (en) * 2006-12-22 2008-07-03 Albert Einstein College Of Medicine Of Yeshiva University Azetidine analogues of nucleosidase and phosphorylase inhibitors
WO2009082247A1 (en) * 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
UA103195C2 (uk) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
EP2348854A4 (en) 2008-09-22 2012-03-14 Einstein Coll Med METHOD AND COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS BY INHIBITING THE "QUORUM SENSING
CA2755950C (en) * 2009-03-24 2017-04-25 Biocryst Pharmaceuticals, Inc. Useful pharmaceutical salts of 7-[(3r,4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
ES2687168T3 (es) * 2009-07-17 2018-10-24 Albert Einstein College Of Medicine, Inc. Inhibidores de 3-hidroxipirrolidina de 5'-metiltioadenosina fosforilasa y nucleosidasa
US9290501B2 (en) 2010-11-29 2016-03-22 Albert Einstein College Of Medicine, Inc. Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
WO2012122532A2 (en) * 2011-03-09 2012-09-13 Biocryst Pharmaceuticals, Inc. Compositions and methods for treatment of hyperuricemia
EP2734186B1 (en) 2011-07-22 2018-09-12 GlaxoSmithKline LLC Composition
WO2014025842A1 (en) * 2012-08-07 2014-02-13 Albert Einstein College Of Medicine Of Yeshiva University Treatment of helicobacter pylori infections
CA2880576A1 (en) 2012-08-24 2014-02-27 Glaxosmithkline Llc Pyrazolopyrimidine compounds
EP2920179A4 (en) 2012-11-12 2016-03-30 Victoria Link Ltd SALT AND POLYMORPHIC FORMS OF (3R, 4S) -L - ((4-AMINO-5H-PYRROLO [3,2-D] PYRIMIDIN-7-YL) METHYL) -4 (METHYLTHIOMETHYL) PYRODIN-3-OL (MTDIA)
CA2890198A1 (en) 2012-11-20 2014-05-30 Diane Mary Coe Novel compounds
RU2643371C2 (ru) 2012-11-20 2018-02-01 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Новые соединения
NZ707319A (en) 2012-11-20 2019-09-27 Glaxosmithkline Llc 5h-pyrrolo[3,2-d]pyrimidin-4-amine compounds and their use in the treatment of allergic diseases and other inflammatory conditions
EP3010507A4 (en) * 2013-06-22 2017-06-07 Nitor Therapeutics Compositions and methods for potentiating immune response for the treatment of infectious diseases and cancer
JP6512613B2 (ja) 2014-02-12 2019-05-15 アルバート アインシュタイン カレッジ オブ メディシン，インコーポレイティド Ｍｔａｎ阻害剤を使用するピロリ菌（ｈ．ｐｙｌｏｒｉ）感染の治療
EP2913333A1 (en) * 2014-02-27 2015-09-02 Laboratoire Biodim 3H-thieno[3,4]pyrimidin-4-one and pyrrolopyrimidone as gram-positive antibacterial agents
CN108794628A (zh) * 2018-05-28 2018-11-13 广东工业大学 一种抗幽门螺杆菌的卵黄抗体制备方法及应用
GB202110403D0 (en) 2021-07-20 2021-09-01 Laevoroc Immunology Ulodesine Salt
GB202218782D0 (en) 2022-12-13 2023-01-25 Mehrling Thomas Purine nucleoside phosphorylase inhibitor for metabolic syndrome
CN117777134B (zh) * 2022-12-19 2025-02-25 艾立康药业股份有限公司 作为mat2a抑制剂的多环类化合物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006548A1 (en) * 1989-10-31 1991-05-16 Biocryst, Inc. Inhibitors of purine nucleoside phosphorylase
JPH07242668A (ja) * 1994-03-08 1995-09-19 Nippon Kayaku Co Ltd 新規なアゼチジン誘導体
JPH10507171A (ja) * 1994-10-05 1998-07-14 カイロサイエンス・リミテッド Ｐｎｐインヒビターとしてのプリンおよびグアニン化合物
HU227726B1 (en) 1995-03-29 2012-01-30 Taiho Pharmaceutical Co Ltd Uracyl-derivatives and antitumor effect potentiator and antitumor agent containing the same
US6379911B2 (en) 1996-02-23 2002-04-30 Albert Einstein College Of Medicine Of Yeshiva University Enzyme detection/assay method and substrates
RU2183639C2 (ru) * 1996-10-16 2002-06-20 Ай-Си-Эн Фармасьютикалз, Инк. Пуриновые l-нуклеозиды, их аналоги и применение
US5985848A (en) * 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
CA2696826C (en) 1999-04-08 2013-01-08 Industrial Research Limited Process for preparing inhibitors of nucleoside metabolism
US6448799B1 (en) * 1999-09-30 2002-09-10 Hitachi Electronics Engineering Co., Ltd. Timing adjustment method and apparatus for semiconductor IC tester
JP4110347B2 (ja) * 1999-11-05 2008-07-02 大鵬薬品工業株式会社 抗ｈｉｖ剤
WO2002018371A1 (en) * 2000-08-29 2002-03-07 Industrial Research Limited Nucleoside metabolism inhibitors
US6458799B1 (en) 2000-08-31 2002-10-01 Biocryst Pharmaceuticals, Inc. Deazaguanine analog, preparation thereof and use thereof
US7098334B2 (en) 2002-03-25 2006-08-29 Industrial Research Limited 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
CN100379750C (zh) 2002-08-21 2008-04-09 阿尔伯爱因斯坦医科叶希瓦大学 核苷磷酸化酶和核苷酶抑制剂
NZ523970A (en) 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
NZ533360A (en) 2004-06-04 2007-02-23 Ind Res Ltd Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
WO2006014913A2 (en) 2004-07-27 2006-02-09 Biocryst Pharmaceuticals, Inc. Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase
NZ540160A (en) 2005-05-20 2008-03-28 Einstein Coll Med Inhibitors of nucleoside phosphorylases
EP1924684A4 (en) 2005-07-27 2009-02-11 Einstein Coll Med Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
NZ544187A (en) 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
JP2009527550A (ja) 2006-02-24 2009-07-30 アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ 癌を処置する方法
US20110092521A1 (en) 2006-02-24 2011-04-21 Richard Hubert Furneaux Methods of Treating Diseases Using Inhibitors of Nucleoside Phosphorylases and Nucleosidases
HRP20110408T1 (hr) 2006-09-07 2011-06-30 Industrial Research Limited Inhibitori nukleozidnih fosforilaza i hidrolaza acikličkog amina
US8383636B2 (en) 2006-09-07 2013-02-26 Industrial Research Limited Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
WO2008039324A1 (en) 2006-09-26 2008-04-03 Albert Einstein College Of Medicine Of Yeshiva University Transition state structure of human 5'-methylthioadenosine phosphorylase
AU2007338953A1 (en) 2006-12-22 2008-07-03 Albert Einstein College Of Medicine Of Yeshiva University Azetidine analogues of nucleosidase and phosphorylase inhibitors
WO2009082247A1 (en) 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
EP2348854A4 (en) 2008-09-22 2012-03-14 Einstein Coll Med METHOD AND COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS BY INHIBITING THE "QUORUM SENSING
ES2687168T3 (es) 2009-07-17 2018-10-24 Albert Einstein College Of Medicine, Inc. Inhibidores de 3-hidroxipirrolidina de 5'-metiltioadenosina fosforilasa y nucleosidasa

Also Published As

Publication number Publication date
CN100379750C (zh) 2008-04-09
AU2003258911A1 (en) 2004-03-11
BRPI0313664B8 (pt) 2021-05-25
US8173662B2 (en) 2012-05-08
EP1539783A4 (en) 2010-05-19
ATE505474T1 (de) 2011-04-15
US20090239885A1 (en) 2009-09-24
HK1085219A1 (zh) 2006-08-18
JP2006501239A (ja) 2006-01-12
US20060160765A1 (en) 2006-07-20
SI1539783T1 (sl) 2011-08-31
DK1539783T3 (da) 2011-06-20
KR101081226B1 (ko) 2011-11-07
DE60336734D1 (de) 2011-05-26
RU2330042C2 (ru) 2008-07-27
KR20050093756A (ko) 2005-09-23
EP1539783B1 (en) 2011-04-13
BRPI0313664B1 (pt) 2021-03-23
AU2003258911B2 (en) 2009-11-19
EP1539783A1 (en) 2005-06-15
ES2363766T3 (es) 2011-08-16
JP4682314B2 (ja) 2011-05-11
US7553839B2 (en) 2009-06-30
CA2496698A1 (en) 2004-03-04
WO2004018496A1 (en) 2004-03-04
PT1539783E (pt) 2011-06-01
BR0313664A (pt) 2005-07-12
CA2496698C (en) 2012-01-24
RU2005107714A (ru) 2006-01-20
CN1692120A (zh) 2005-11-02

Similar Documents

Publication Publication Date Title
CY1111700T1 (el) Αναστολεις των νουκλεοζιτικων φωσφορυλασων και νουκλεοζιδασων
ATE552259T1 (de) Inhibitoren von nukleosidphosphorylasen und - nukleosidasen
ATE502038T1 (de) Azyklische amininhibitoren von nukleosidphosphorylasen und hydrolasen
CY1115580T1 (el) Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξικης πιπεραζινης
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
MEP36208A (en) Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
CY1108146T1 (el) ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ β-ΑΜΙΝΟ-ΕΤΕΡΟΚΥΚΛΙΚΗΣ-ΔΙΠΕΠΤΙΔΥΛΙΚΗΣ ΠΕΠΤΙΔΑΣΗΣ ΓΙΑ ΤΗΝ ΑΓΩΓΗ Ή ΠΡΟΛΗΨΗ ΤΟΥ ΔΙΑΒΗΤΗ
MEP36908A (en) omega-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
CY1110784T1 (el) Ιατρικη χρηση της τετρα-υδροτριαζολο[4,3-α]πυραζινης
TR200103576T2 (tr) Üre ikameli/katkılı imidazokinolinler.
ATE497770T1 (de) Pharmazeutische formulierungen von decitabin
ATE448232T1 (de) Substituierte heterozyklen
TNSN05265A1 (en) Composition comprising a pde4 inhibitor and a pde5 inhibitor
SE0302304D0 (sv) Novel compounds
ATE547104T1 (de) Zusammensetzung enthaltend einen lungensurfactant und sildenafil zur behandlung von lungenerkrankungen
DE60318694D1 (de) 4-(pyrrolopyrimidin-6-yl)benzolsulfonamidderivate
BR0313048A (pt) Uso de alquilfosfocolinas em combinação com medicamentos antitumorais
NO20053903L (no) Nukleotidlipidesterderivater.
DE602004007284D1 (de) Pyrimidine als inhibitoren von phosphoinositid-3-kinasen (pi3k)
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
TR200103398T2 (tr) íkameli fenilsikloheksankarboksamitler ve bunlarìn adenozin alìnìmìnìn inhibit”rleri olarak kullanìmì
SE0001531D0 (sv) Medicament for the treatment of diseases caused by parasiticprotozoa
CY1114697T1 (el) Αντισωματα ιντερφερονης αλφα και οι χρησεις αυτων